Labiana Health S.A. (MC:LAB) — Market Cap & Net Worth
Market Cap & Net Worth: Labiana Health S.A. (LAB)
Labiana Health S.A. (MC:LAB) has a market capitalization of $58.58 Million (€50.10 Million) as of July 22, 2026. Listed on the MC stock exchange, this Spain-based company holds position #21262 globally and #149 in its home market, demonstrating a -1.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labiana Health S.A.'s stock price €6.60 by its total outstanding shares 8489255 (8.49 Million). See LAB capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Labiana Health S.A. Market Cap History: 2022 to 2026
Labiana Health S.A.'s market capitalization history from 2022 to 2026. Data shows growth from $33.35 Million to $65.50 Million (9.27% CAGR).
Labiana Health S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labiana Health S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.44x
Labiana Health S.A.'s market cap is 0.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
115.91x
Labiana Health S.A.'s market cap is 115.91 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $33.35 Million | $57.85 Million | -$8.94 Million | 0.58x | N/A |
| 2023 | $12.41 Million | $58.46 Million | -$4.42 Million | 0.21x | N/A |
| 2024 | $29.38 Million | $66.26 Million | $253.45K | 0.44x | 115.91x |
Competitor Companies of LAB by Market Capitalization
Companies near Labiana Health S.A. in the global market cap rankings as of July 22, 2026.
Key companies related to Labiana Health S.A. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #505 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #515 globally with a market cap of $51.87 Billion USD ( CN¥354.48 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #548 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #617 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #505 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #515 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $51.87 Billion | CN¥55.57 |
| #548 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.46 |
| #617 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Labiana Health S.A. Historical Marketcap From 2022 to 2026
Between 2022 and today, Labiana Health S.A.'s market cap moved from $33.35 Million to $ 65.50 Million, with a yearly change of 9.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €65.50 Million | +36.36% |
| 2025 | €48.04 Million | +63.51% |
| 2024 | €29.38 Million | +136.80% |
| 2023 | €12.41 Million | -62.80% |
| 2022 | €33.35 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of Labiana Health S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $58.58 Million USD |
| MoneyControl | $58.58 Million USD |
| MarketWatch | $58.58 Million USD |
| marketcap.company | $58.58 Million USD |
| Reuters | $58.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more